USPTO serial 77353871
ACCREDO HEALTH
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SHANAHAN, PATRICK
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ACCREDO HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Grady M. Garrison
GRADY M. GARRISON BAKER, DONELSON, BEARMAN, CALDWELL & BERKOWITZ, PC165 MADISON AVE STE 2000MEMPHIS, TN 38103-2799UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of chronic diseases, namely, alpha-1 antitrypsin deficiency, moderate to severe persistent asthma, pulmonary arterial hypertension, respiratory syncytial virus, chronic, moderate to severe plaque psoriasis, hereditary tyrosinemia type 1, autoimmune disorders and primary immune deficiencies, growth hormone deficiency, Fabry disease, rheumatoid arthritis, psoriatic arthritis, hemophilia, Gaucher disease, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, multiple sclerosis, hypomobility associated with advanced Parkinson's disease, MPS 1, severe combined immunodeficiency disease, chronic granulomatour disease, severe malignant osterpetrosis; pharmaceutical preparations for use as blood clotting agents used in the control of hemophilia; pharmaceutical preparations for the treatment of chronic diseases, namely disorders requiring intravenous immunoglobulin therapy; pharmaceutical preparations for the treatment of hemophilia | ACTIVE | — |
| 016 | Printed publications, namely, magazines featuring articles and information on blood disorders; newsletters and pamphlets featuring a series of stories on the subject of living with hemophilia; newsletters on the subject of hemophilia and related health issues | ACTIVE | — |
| 035 | Retail pharmacy services specializing in the treatment and control of chronic diseases; retail pharmacy services specializing in the control of hemophilia | ACTIVE | — |
| 036 | Providing information about government benefits and entitlements, and insurance, and related social services to people with chronic diseases and other health conditions | ACTIVE | — |
| 041 | Providing patient educational services, namely, conducting programs in the field of chronic disease, proper product-reconstitution and administration, and resources appropriate for support of disease management; educational services for product manufacturers, pharmaceutical clinicians and biotech companies, clinicians, contract research organizations and insurance providers, namely, conducting classes, one-on-one sessions and telephonic workshops in the field of clinical education and distributing course materials in connection therewith; educational services, namely, classes, one on one sessions and telephonic workshops which provide physicians, insurance companies and patients with specific characteristics associated with disease management products; educational services and resources, namely, conducting workshops for children to help them to understand hemophilia; educational services, namely, conducting workshops for children to help them understand hemophilia | ACTIVE | — |
| 042 | Providing clinical research in the field of medicine for product manufacturers, pharmaceutical and biotech companies, contract research organizations and insurance providers, and providing consulting services in support of new drug product launches; medical services, namely, on-line analysis of infusion and bleeding activity for hemophiliacs | ACTIVE | — |
| 044 | Nursing care specializing in the treatment, prevention and control of chronic diseases; nursing care specializing in the treatment, prevention and control of hemophilia; medical services, namely, administration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia; administration of pharmaceutical preparations used in the treatment of chronic diseases; providing information concerning medical care and treatment in the field of hemophilia; disease management services; telephone hotline counseling, namely, offering healthcare advice regarding bleeding disorders; services consisting of providing nutritional guidance and consultation to chronically ill patients; medical services, namely, specialized pharmaceutical advice for individuals with bleeding disorders | ACTIVE | — |
| 045 | Providing patient advocate services to people with chronic diseases and other health conditions regarding government benefits and entitlements, and insurance, and related social services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Accredo Health Group, Inc.
- Other trademarks owned by Accredo Health Group, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named ACCREDO HEALTH
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 22, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 22, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 18, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 26, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 6, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 22, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 22, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jul 22, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 21, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 21, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 21, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 24, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 20, 2007 | NWAP | NEW APPLICATION ENTERED | — |